/Lists

Biotech Series A Investors & VC Firms

1626 firms in this list, with a median first check of $500K. 369 of them lead rounds. Generated from verified public data and updated continuously.

Northern Gritstone
ManchesterSeed–Growth
41 people
Blue Venture Funds
ChicagoSeed–Late Stage$1M – $20M
28 people
Novartis Venture Fund
BaselSeed–Growth$5M – $25M
21 people
LongeVC
Washington D.C.Pre-Seed–Series A
42 people
Hoxton Ventures
LondonPre-Seed–Series A$500K – $5M
10 people
5Y Capital
ShanghaiSeed–Growth
22 people
Primo Ventures
MilanPre-Seed–Growth$1.1M
17 people
Rho Ventures
New YorkPre-Seed–Growth$2M – $15M
11 people
Dreamers VC
El SegundoSeed–Series B$500K – $5M
10 people
Supermoon Capital
San FranciscoPre-Seed–Series A$150K – $2.5M
36 people
NYU Innovation Venture Fund
New York CityPre-Seed–Series A$100K – $500K
32 people
Clarendon Fund Managers Ltd.
BelfastPre-Seed–Growth$63K – $3.8M
13 people
Visionaries Club
BerlinPre-Seed–Series B$900K
22 people
Berkeley Frontier
BerkeleyPre-Seed–Late Stage
40 people
BioGeneration Ventures
NaardenPre-Seed–Late Stage
26 people
VantagePoint Capital Partners
Silicon ValleySeed–Growth$2M – $100M
18 people
DAYLI Partners
SeoulSeed–Late Stage
13 people
Gen Capital
ChicagoPre-Seed–Series A
24 people
T. Rowe Price
BaltimoreSeed–Series C
6 people
Blue Revolution Investments G.P.
BergenSeed–Series A
31 people
SeaX Ventures
MillbraePre-Seed–Series A$100K – $5M
35 people
META Group
BrusselsSeed–Series A
42 people
Avoro Capital Advisors
New YorkSeries A–Late Stage
22 people
AIF
New YorkSeed–Growth
39 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.